| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.26 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |